wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39967942-92B9E954-1548-49FF-8EC6-BBD2CCF43372
Q39967942-92B9E954-1548-49FF-8EC6-BBD2CCF43372
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39967942-92B9E954-1548-49FF-8EC6-BBD2CCF43372
A phase III trial of exemestane plus bevacizumab maintenance therapy in patients with metastatic breast cancer after first-line taxane and bevacizumab: a GINECO group study.
P2860
Q39967942-92B9E954-1548-49FF-8EC6-BBD2CCF43372
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39967942-92B9E954-1548-49FF-8EC6-BBD2CCF43372
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
26ef6ce6b546ff7dec84dd0027a7e9cbbd5f72d6
P2860
Maintenance bevacizumab beyond first-line paclitaxel plus bevacizumab in patients with Her2-negative hormone receptor-positive metastatic breast cancer: efficacy in combination with hormonal therapy.